TickerFactsScreenerDevelopers

VERTEX PHARMACEUTICALS INC / MA (VRTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2008: -$226.48M2009: -$427.59M2010: -$635.44M2011: $143.74M2012: $267.84M2013: -$60.67M2014: -$573.11M2015: -$365.43M2016: $236.10M2017: $844.94M2018: $1.27B2019: $1.57B2020: $3.25B2021: $2.64B2022: $4.13B2023: $3.54B2024: -$492.60M2025: $3.63B$3.63B
2008Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025$3.63B+837.2%
2024-$492.60M-113.9%
2023$3.54B-14.3%
2022$4.13B+56.2%
2021$2.64B-18.7%
2020$3.25B+107.3%
2019$1.57B+23.5%
2018$1.27B+50.3%
2017$844.94M+257.9%
2016$236.10M+164.6%
2015-$365.43M+36.2%
2014-$573.11M-844.7%
2013-$60.67M-122.7%
2012$267.84M+86.3%
2011$143.74M+122.6%
2010-$635.44M-48.6%
2009-$427.59M-88.8%
2008-$226.48M—